Clinical Trial Update: A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of HSK31858 in non-cystic fibrosis bronchiectasis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• HSK31858 (HSK31858)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Non-cystic Fibrosis Bronchiectasis | Phase 3 | Status: RECRUITING